Alvin Wong
Chief Tech/Sci/R&D Officer chez PUMA BIOTECHNOLOGY, INC.
Fortune : 748 577 $ au 31/03/2024
Profil
Alvin F.
Wong is currently the Chief Scientific Officer at Puma Biotechnology, Inc. He previously worked as the Senior Director-Clinical Development at Proteolix, Inc. from 2007 to 2013.
Prior to that, he served as a Clinical Professor at UCSF School of Pharmacy from 1976 to 1996.
Dr. Wong holds a graduate degree from The University of California, San Francisco.
Détentions connues dans des sociétés publiques
Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
---|---|---|---|---|
PUMA BIOTECHNOLOGY, INC.
0,29% | 12/02/2024 | 141 241 ( 0,29% ) | 748 577 $ | 31/03/2024 |
Postes actifs de Alvin Wong
Sociétés | Poste | Début |
---|---|---|
PUMA BIOTECHNOLOGY, INC. | Chief Tech/Sci/R&D Officer | 01/08/2017 |
Anciens postes connus de Alvin Wong
Sociétés | Poste | Fin |
---|---|---|
Proteolix, Inc.
Proteolix, Inc. Pharmaceuticals: MajorHealth Technology Proteolix, Inc. manufactures bio-pharmaceutical related products. It engages in the discovery, development, and marketing of pharmaceutical products to treat cancer and immunological conditions. The company was founded by Susan M. Molineauxf in December 2003 and is headquartered in South San Francisco, CA | Corporate Officer/Principal | 01/01/2013 |
UCSF School of Pharmacy | Corporate Officer/Principal | 01/01/1996 |
Formation de Alvin Wong
The University of California, San Francisco | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 1 |
---|---|
PUMA BIOTECHNOLOGY, INC. | Health Technology |
Entreprise privées | 1 |
---|---|
Proteolix, Inc.
Proteolix, Inc. Pharmaceuticals: MajorHealth Technology Proteolix, Inc. manufactures bio-pharmaceutical related products. It engages in the discovery, development, and marketing of pharmaceutical products to treat cancer and immunological conditions. The company was founded by Susan M. Molineauxf in December 2003 and is headquartered in South San Francisco, CA | Health Technology |